In "Episode 2" of the series on "Present and future of diagnostics in prostate cancer," Prof. Monique Roobol (NL) and Dr. Tamás Fazekas (HU) review the ongoing debate surrounding prostate cancer screening.
They review the history and development of screening strategies, including the key findings from early trials and the progression toward more personalised, risk-stratified approaches.
Prof. Roobol discusses the significance of PSA testing and how it serves as a tool for initial risk stratification, while also addressing...